Login / Signup

Efficacy and safety of silymarin containing antioxidant serum as an adjuvant treatment of mild-to-moderate acne vulgaris: A prospective, open-label pilot study.

Jemin KimYun Na LeeJoohee LeeSang Gyu LeeHyun KimYe Seul ChoiZoe Diana DraelosJihee Kim
Published in: Journal of cosmetic dermatology (2022)
The 0.5% silymarin-containing antioxidant formulation improved acne's clinical severity and related skin biophysical parameters.
Keyphrases
  • open label
  • oxidative stress
  • anti inflammatory
  • hidradenitis suppurativa
  • clinical trial
  • early stage
  • drug delivery
  • soft tissue
  • study protocol
  • phase ii
  • wound healing
  • replacement therapy